Immix Biopharma Target Price

See Immix Biopharma's analyst price targets ($20) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$10.92

Average Target Price

$20.00

83.2% upside

1 analysts in the last 4 months

High: $20 | Low: $20

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-05-22	H.C. WainwrightRobert Burns	$20	83.2% upside
2026-03-27	H.C. Wainwright	$15	37.4% upside
2026-02-09	Mizuho SecuritiesGraig Suvannavejh	$14	28.2% upside
2025-12-09	H.C. Wainwright	$12	9.9% upside
2024-07-01	H.C. WainwrightRobert Burns	$7	35.9% downside

Immix Biopharma (IMMX) FAQ

Immix Biopharma (IMMX) currently reports a target price of $20. Use the charts on this page to explore Immix Biopharma's target price history and peer comparisons.

Analysts' average 12-month price target for Immix Biopharma is $20, about 83.2% upside from the current share price of $10.92. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $20, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Immix Biopharma, and consider following IMMX for alerts when major investors trade the stock.